Experimental Ovarian Cancer Vaccine Shows Promise in Mice

The experimental vaccine targets a protein found at elevated levels in about 90% of the most common type of ovarian cancer. If validated in human studies, researchers believe the vaccine may be particularly useful for women who carry BRCA1 and BRCA2 gene mutations.

Cancer Currents: An NCI Cancer Research Blog